Dulaglutide-Associated Choroidal Lymphoid Hyperplasia

New England Journal of Medicine 2026 Open access

Read full text
Authors: Jasmine H. Francis, Robin B. Mendelsohn, Julia Canestraro, Lisa R. Koenig, Peter E. Weseley, David H. Abramson, Lorenzo Falchi
DOI: 10.1056/nejmc2600397
Cited by: 3
References: 5

Abstract

This letter describes two adult patients in whom choroidal lymphoid hyperplasia developed in one eye after dulaglutide, a GLP-1 receptor agonist, was initiated. Findings resolved after dulaglutide was discontinued.

Fields of Study & Subjects

Autoimmune Neurological Disorders and Treatments Drug-Induced Ocular Toxicity Chronic Lymphocytic Leukemia Research

Publication details

Journal / source
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Volume
394
Issue
19
Pages
1959–1961
Publication date
13 May 2026
Language
EN